SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001548233-13-000024
Filing Date
2013-11-08
Accepted
2013-11-08 17:02:09
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q QUARTERLY REPORT cellceutix_10q2q13.htm 10-Q 871731
2 EXHIBIT 31.1 ex31-1.htm EX-31 9589
3 EXHIBIT 31.2 ex31-2.htm EX-31 9354
4 EXHIBIT 32.1 ex32-1.htm EX-32 4075
5 EXHIBIT 32.2 ex32-2.htm EX-32 4196
  Complete submission text file 0001548233-13-000024.txt   5656219

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ctix-20130930.xml EX-101.INS 723045
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctix-20130930.xsd EX-101.SCH 66344
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctix-20130930_cal.xml EX-101.CAL 36486
9 XBRL TAXONOMY DEFINITION LINKBASE DOCUMENT ctix-20130930_def.xml EX-101.DEF 245455
10 XBRL TAXONOMY LABEL LINKBASE DOCUMENT ctix-20130930_lab.xml EX-101.LAB 491796
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctix-20130930_pre.xml EX-101.PRE 339466
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 (978)-633-3623
Cellceutix CORP (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-52321 | Film No.: 131205576
SIC: 2834 Pharmaceutical Preparations